Delivery Order SPE2DB24D3013-SPE2DB25FFJLK

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FEW07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,852.72 firm fixed-price delivery order is for the supply of VERZENIO 50 MG TABLET UU 14S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,221.03 fixed-price delivery order contract is for the supply of VERZENIO 100 MG TABLET medical products. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MUP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,213.26 firm fixed-price delivery order is for the supply of "VERZENIO 150 MG TABLET UU 14S" medical products. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) is a $26,514.16 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of VERZENIO 150 MG TABLET, a medication, with a completion date of January 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,792.07 firm fixed-price delivery order is for VERZENIO 100 MG TABLET UU 14S, a pharmaceutical product. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF2UR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,245.28 firm fixed-price delivery order is for the supply of VERZENIO 50 MG TABLET UU 14S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,344.34, is for the delivery of VERZENIO 150 MG TABLET pharmaceutical products. The contract is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,715.33 firm fixed-price delivery order is for the supply of VERZENIO 50 MG TABLET medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, SPE2DX15D3108|SPE2DX24F27FF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $9,316.97 firm fixed price delivery order is for the supply of VERZENIO 150 MG TABLET pharmaceutical products. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of VERZENIO 150 MG TABLET UU 14S to the Defense Logistics Agency (DLA). The $8,505.88 firm fixed-price delivery order contract has a completion date of January 16, 2025. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a wide range of...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFJLK
    Delivery Order

The federal contract award SPE2DB24D3013|SPE2DB25FFJLK was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $8,662.70 firm fixed price delivery order is for the supply of VERZENIO 150 MG TABLET UU 14S, a pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/13/25, 10:10 AM